- Vaccine and Biopharmaceutical Manufacturing & Quality Control Training Held from November 5 to 7
- Practical, Hands-on Program Covering Microbiological and Physicochemical Testing, Cell Culture, and Purification Processes
▲QC Training: Protein Quantification Session
The PCMO (Director Min Cho) in Hwasun, Jeollanam-do, announced that it conducted a three-day on-site practical training program from November 5 to 7 for trainees participating in the “2025 Vaccine (Biopharmaceutical) Quality Control Basic Training Course (GxP Program)” organized by the International Vaccine Institute (IVI). Following last year’s program, this year marks the second round of practical training provided by the Center. A total of 25 trainees from 16 countries were selected to participate, out of more than 200 GxP program participants representing 40 countries worldwide.
This program is part of the Global Bio Workforce Training Hub (GTH-B) initiative led by the World Health Organization (WHO) to strengthen global capacity for infectious disease response. Through this year’s training, PCMO once again demonstrated its world-class facilities and capabilities in vaccine manufacturing and quality control.
▲Purification Laboratory Tour within the Training Center
The training program was centered around the theme of current Good Manufacturing Practices (cGMP) and combined theory with extensive practical sessions to deepen understanding. Key components included ▲a cGMP manufacturing site tour ▲hands-on manufacturing process training ▲QC (Quality Control) physicochemical testing ▲ a virtual reality (VR) experience of cell culture and purification processes. These activities allowed participants to gain direct, practical experience across the full spectrum of biopharmaceutical production.
▲Group Photo of Participants
In particular, this year’s course emphasized microbiological and physicochemical testing practices. Trainees conducted monitoring exercises to evaluate cleanroom environments and water quality, learning how to maintain product integrity throughout the manufacturing process. They also performed step-by-step operations from Cell Bank preparation and bioreactor operation to sensor calibration and sampling during cell culture, thereby enhancing their comprehension of the entire production workflow.
Mr. Jin-young Song, Head of the External Relations Team at the Center, stated, “This training provided an excellent opportunity to expand global collaboration in the field of biopharmaceutical production and quality control. We will continue to contribute to developing skilled professionals for the global vaccine industry through close cooperation with international organizations and partner institutions.”
▲Exterior View of the Microbial Demonstration Support Center
Meanwhile, the PCMO opened the largest biomanufacturing training facility in Jeollanam-do in July and has since been operating in full scale. The facility is equipped with advanced instruments that enable hands-on practice in biopharmaceutical production and testing, attracting growing interest from students and industry professionals alike. Looking ahead, the PCMO aims to strengthen its position as a key regional hub for biopharmaceutical talent development.